Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Employees - 60500,
CEO - Ms. Sarah M. London,
Sector - Healthcare,
Country - US,
Market Cap - 28.04B
Altman ZScore(max is 10): 2.81, Piotroski Score(max is 10): 6, Working Capital: $3738000000, Total Assets: $82445000000, Retained Earnings: $15348000000, EBIT: 4959000000, Total Liabilities: $55935000000, Revenue: $163071000000
- Current Price $56.53 - Analyst Target Price $78.17Ticker | CNC |
Index | S&P 500 |
Curent Price | 56.53 |
Change | -8.20% |
Market Cap | 28.04B |
Average Volume | 4.72M |
Income | 3.31B |
Sales | 163.07B |
Book Value/Share | 53.26 |
Cash/Share | - |
Dividend Est | 1.25 (2.21%) |
Dividend TTM | - |
Dividend Ex-Date | - |
Employees | 60500 |
Moving Avg 20days | -7.87% |
Moving Avg 50days | -5.39% |
Moving Avg 200days | -13.15% |
Shares Outstanding | 495.91M |
Earnings Date | Apr 25 BMO |
Inst. Ownership | 98.64% |
Price/Earnings | 9.05 |
Forwad P/E | 7.05 |
PE Growth | 0.98 |
Price/Sales | 0.17 |
Price/Book | 1.06 |
Price/Cash | - |
Price/FCF | - |
Quick Ratio | - |
Current Ratio | 1.11 |
Debt/Equity | 0.74 |
Return on Assets | 3.90% |
Return on Equity | 12.65% |
Return on Investment | 7.25% |
Gross Margin | - |
Ops Margin | 2.01% |
Profit Margin | 2.03% |
RSI | 38.43 |
BETA(β) | 0.47 |
From 52week Low | 2.73% |
From 52week High | -29.85% |
EPS | 6.25 |
EPS next Year | 8.02 |
EPS next Qtr | 2.20 |
EPS this Year | 1.65% |
EPS next 5 Year | 9.26% |
EPS past 5 Year | 14.96% |
Sales past 5 Year | 17.88% |
EPS Y/Y | 27.09% |
Sales Y/Y | 5.89% |
EPS Q/Q | 573.60% |
Sales Q/Q | 3.41% |
Sales Surprise | 9.03% |
EPS Surprise | 15.05% |
ATR(14) | 2.53 |
Perf Week | -6.87% |
Perf Month | -6.62% |
Perf Quarter | -12.47% |
Perf Year | -25.46% |
Perf YTD | -6.69% |
Target Price | 78.17 |
AryaFin Engine© - An AI FinTech Venture - 2024-25 Disclaimer